14 unknown. 14 Phase 2, 4 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Unknown 14 |
| Phase 3 | 4 | Unknown 4 |
| Phase 1 | 3 | Unknown 3 |
Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Stapokibart Injection in Patients With Allergic Rhinitis Stapokibart Injection, Placebo - Allergic Rhinitis | Phase 2 | Unknown | Keymed Biosciences Co.Ltd | 120 | 2024-09-30 | 2024-11-08 |
| Study of CM310 in Subjects With Seasonal Allergic Rhinitis CM310 - Seasonal Allergic Rhinitis | Phase 2 | Unknown | Keymed Biosciences Co.Ltd | 100 | 2024-03-30 | 2023-12-14 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis. GR1802 injection-1, GR1802 injection-2, Placebo - Allergic Rhinitis | Phase 2 | Unknown | Zheng Liu ENT | 90 | 2023-09-07 | 2023-09-11 |
| Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.). - Allergic Rhinitis | Phase 2 / Phase 3 | Unknown | People's Hospital of Anshun City of Guizhou Province | 60 | 2022-12-01 | 2022-10-06 |
| Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells Olfactory mucosa-derived mesenchymal stem cells, Standard treatment of type Allergic Rhinitis according to the clinical protocols, Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols - Allergic Rhinitis, Rhinosinusitis Chronic | Phase 1 / Phase 2 | Unknown | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 60 | 2022-03-01 | 2022-01-19 |
| Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline Minocycline Topical, Placebos - Allergic Rhinitis, Asthma | Phase 2 | Unknown | State University of New York - Downstate Medical Center | 25 | 2019-09-26 | 2021-10-14 |
| Sanfu Herbal Patch and Sanfu Moxibustion for Persistent Allergic Rhinitis: a Controlled Clinical Trial Sanfu herbal patch, Sanfu moxibustion, Sanfu herbal patch and moxibustion - Patch,Chinese Herb, Moxibustion | Phase 2 | Unknown | Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust | 200 | 2016-07-01 | 2018-03-26 |
| Allergic Rhinitis, Immunotherapy and Vitamin d Vitamin D3, placebo - Allergy | Phase 2 / Phase 3 | Unknown | Hospital General de Mexico | 60 | 2016-03-01 | 2016-04-14 |
| StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study PSE 120 mg, CM 8 mg, Atr 0.36 mg, PSE 120 mg, CM 8 mg, Atr 0.24 mg, PSE 120 mg, CM 8 mg, Atr 0.12 mg - Rhinitis, Seasonal, Allergic | Phase 2 | Unknown | Magna Pharmaceuticals, Inc. | 125 | 2014-03-01 | 2014-05-30 |
| A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis Azelastine HCl and Fluticasone Propionate Nasal Spray, 137 µg/50 µg per spray, Dymista™ Nasal Spray, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Unknown | Apotex Inc. | 595 | 2013-12-01 | 2014-10-31 |
| The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions Allergen(Tree, Grass, Weeds) - Allergic Rhinitis, Asthma | Phase 1 / Phase 2 | Unknown | University Hospitals Cleveland Medical Center | 245 | 2013-04-01 | 2013-06-17 |
| Safety and Efficacy Study of rEV131 in Allergic Rhinitis topical nasal rEV131 - Hay Fever | Phase 1 / Phase 2 | Unknown | Evolutec Group | 112 | 2005-05-01 | 2005-11-02 |
| EWO1 in Persistent Allergic Rhinitis Patients EWO1 - Rhinitis, Allergic, Perennial | Phase 2 / Phase 3 | Unknown | China Medical University Hospital | 60 | 2004-11-01 | 2007-07-25 |
| Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 Mixture of probiotic bacteria and prebiotic oligosaccharide - Atopic Dermatitis, Food Hypersensitivity | Phase 2 / Phase 3 | Unknown | University of Helsinki | 1999-10-01 | 2006-10-18 |
Rhinitis, Allergic, Seasonal (5) · Asthma (3) · Conjunctivitis, Allergic (2) · Hypersensitivity (2) · Rhinitis, Allergic, Perennial (2) · Dermatitis, Atopic (1) · Food Hypersensitivity (1) · Rhinitis (1)
Hypersensitivity, Immediate (14) · Immune System Diseases (14) · Nose Diseases (14) · Otorhinolaryngologic Diseases (14) · Respiratory Hypersensitivity (14) · Respiratory Tract Diseases (14) · Rhinitis (13) · Hypersensitivity (12) · Bronchial Diseases (3) · Lung Diseases (3) · Lung Diseases, Obstructive (3) · Conjunctival Diseases (2) · Conjunctivitis (2) · Eye Diseases (2)
Atropine (1) · Chlorpheniramine (1) · Cholecalciferol (1) · Minocycline (1) · Moxibustion (1) · Proto-Oncogene Proteins c-raf (1) · Pseudoephedrine (1) · Vitamin D (1) · azelastine (1) · nabiximols (1)
Keymed Biosciences Co.Ltd (2) · Apotex Inc. (1) · China Medical University Hospital (1) · Evolutec Group (1) · Hospital General de Mexico (1) · Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust (1) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1) · Magna Pharmaceuticals, Inc. (1) · People's Hospital of Anshun City of Guizhou Province (1) · State University of New York - Downstate Medical Center (1) · University Hospitals Cleveland Medical Center (1) · University of Helsinki (1) · Zheng Liu ENT (1)
China (5) · United States (4) · Finland (1) · Mexico (1) · Taiwan (1)
Luo Zhang (2) · Devi K Jhaveri, D.O. (1) · Erkki Savilahti, Professor (1) · Fangming Chen, MB (1) · Guangjun Tang, MD (1) · Haig Tcheurekdjian, M.D. (1) · Long Chai, MM (1) · Min-Chien Yu, Ph.D. (1) · Natalia Antonevich, Dr (1) · Rauno O Joks (1) · Stephen J Pollard, MD (1) · Wynne H Weston-Davies, MB FRCS (1) · Yulia Eremenko, Prof (1)
PMID 12668793, PMID 14674933, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15750716, PMID 15898976, PMID 16930249, PMID 18331513, PMID 18595980, PMID 19925886, PMID 19968632, PMID 20545698, PMID 20816182, PMID 21122901, PMID 21771118, PMID 21783242, PMID 22093109, PMID 22224763, PMID 22627366, PMID 23348417, PMID 23791985, PMID 24631153, PMID 24679069, PMID 25171868, PMID 25644617, PMID 26141263, PMID 26874355, PMID 26922931, PMID 26932169, PMID 26949057, PMID 28602936, PMID 28785597, PMID 28917723, PMID 29214012, PMID 29771013, PMID 29774680, PMID 30142344, PMID 30233198, PMID 30263032, PMID 30326954, PMID 30472801, PMID 33273461, PMID 34857814, PMID 37438187, PMID 38687061, PMID 9042022